Lurasidone - Schizophrenia and other psychoses
You are here : Home > Formulary Search > Lurasidone - Schizophrenia and other psychoses
I agree that in using this database I understand that this platform only provides guidance on local prescribing policy and that all prescribing decisions are ultimately the responsibility of the clinician.
Documentation
Guidelines (Local)
Evidence Review
PAD Profile
ChemicalSubstance :
Lurasidone
Indication :
Schizophrenia and other psychoses
Group Name :
Keywords :
antipsychotics
Brand Names Include :
Latuda
Important Information :
Latest Additions Date From :
Latest Additions Date To :
Guidelines :
Supporting Documents :
3
Other Indications
Below are listed other indications that Lurasidone is used to treat.
- No records returned.
Other Drugs
Below are listed other drugs that are used to treat Schizophrenia and other psychoses.
Committee Recommendations (1)
The PCN recommends lurasidone as a treatment option in the management of schizophrenia once metabolic syndrome has been identified. Lurasidone will be initiated by a specialist from Surrey & Borders Partnership NHS Foundation Trust, in line with the lurasidone prescribing pathway (see Documentation). Transfer of prescribing responsibility (to primary care) may be considered following 3 months initial treatment by the specialist.